Benjamin Cieply, PhD
Global Health Economics and Outcomes Research
Connect with me
Benjamin Cieply is an experienced consultant with ICON’s Global Health Economics and Outcomes Research team. He has been largely focused on drugs in development, aiming to help clients understand their asset’s value and price potential and the evidence needed to support this. Ben’s experience and knowledge of the payer landscape and pricing and access projects spans the US, Europe, and rest of world and emerging markets and has focused multiple engagements on cell and gene therapies. Ben is an author on 25 peer reviewed publications in scientific and medical journals and he earned his Doctorate of Philosophy (Ph.D.) in Cancer Cell Biology from the University of West Virginia School of Medicine.